Financhill
Back

Arcturus Therapeutics Holdings Vs. Liquidia Industry Stock Comparison

Sell
38

ARCT
Arcturus Therapeutics Holdings

Last Price:
18.25
Seasonality Move:
9.45%
Sell
37

LQDA
Liquidia

Last Price:
10.64
Seasonality Move:
23.2%
Sell
38
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?

  • The current Arcturus Therapeutics Holdings [ARCT] share price is $18.33. The Score for ARCT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Liquidia (LQDA) is a Sell

Is Liquidia a Buy, Sell or Hold?

  • The current Liquidia [LQDA] share price is $10.64. The Score for LQDA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • LQDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARCT Stock Price Chart

What is Arcturus Therapeutics Holdings's stock price today?

  • The Arcturus Therapeutics Holdings share price today is $18.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing slight selling pressure.

LQDA Stock Price Chart

What is Liquidia's stock price today?

  • The Liquidia share price today is $10.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LQDA is experiencing slight buying pressure.

ARCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.95 Sell
Relative Strength Index (14 RSI): 38.3 Sell
Chaikin Money Flow: -183326 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.41 - 22.73) Sell
Bollinger Bands (100): (19.25 - 24.25) Sell

LQDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 46.43 Sell
Chaikin Money Flow: 343787 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.51 - 11.31) Sell
Bollinger Bands (100): (9.89 - 12.25) Sell

ARCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.42 Sell
20-day SMA: 19.68 Sell
50-day SMA: 20.68 Sell
200-day SMA: 27.62 Sell
8-day EMA: 18.5 Sell
20-day EMA: 19.5 Sell
50-day EMA: 20.7 Sell
200-day EMA: 24.74 Sell

LQDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.81 Sell
20-day SMA: 11.02 Sell
50-day SMA: 10.31 Buy
200-day SMA: 12.45 Sell
8-day EMA: 10.75 Sell
20-day EMA: 10.81 Sell
50-day EMA: 10.77 Sell
200-day EMA: 11.16 Sell

Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.49 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and an increase next year of $1.47 per share.

Liquidia Earnings Growth & LQDA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $0.39 per share.

Arcturus Therapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Liquidia Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):